Wells Fargo’s Jaguar Health JAGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15 Hold
1
– – ﹤0.01% 6999
2026
Q1
$74 Buy
+1
New +$164 ﹤0.01% 6539
2024
Q2
– Hold
0
– -$34 – 7181
2024
Q1
– Hold
0
– – – 6947
2023
Q4
– Hold
0
– – – 7250
2023
Q3
– Hold
0
– – – 7066
2023
Q2
– Hold
0
– – – 7043
2023
Q1
– Hold
0
– – – 7538
2022
Q4
– Hold
0
– – – 6932
2022
Q3
– Hold
0
– – – 7004
2022
Q2
– Hold
0
– – – 7148
2022
Q1
– Hold
0
– – – 7436
2021
Q4
– Hold
0
– – – 7515
2021
Q3
– Hold
0
– – – 6727
2021
Q2
– Hold
0
– – – 6680
2021
Q1
– Hold
0
– – – 6732
2020
Q4
– Hold
0
– – – 6741
2020
Q3
– Hold
0
– – – 6607
2020
Q2
– Hold
0
– – – 6549
2020
Q1
– Hold
0
– – – 6495

Other funds holding JAGX

Wells Fargo's JAGX Position: Q2 2026 in Review

Wells Fargo held its Jaguar Health (JAGX) position steady in Q2 2026 at 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #6999.

Wells Fargo first reported a position in JAGX in Q1 2026 and has held it in 2 quarters since. The position peaked at $74 in Q1 2026. 7 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

  • Wells Fargo held 1 share of Jaguar Health worth $15 as of Q2 2026.
  • Wells Fargo left its Jaguar Health share count unchanged in Q2 2026.
  • Jaguar Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6999 holding.
  • Wells Fargo first reported a position in Jaguar Health in Q1 2026 and has held it in 2 quarters since.
  • Wells Fargo's Jaguar Health position peaked at $74 in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.